Exicure - Stock Price History | XCUR

Historical daily share price chart and data for Exicure since 2021 adjusted for splits. The latest closing stock price for Exicure as of September 27, 2021 is 1.29.
  • The all-time high Exicure stock closing price was 3.65 on December 12, 2019.
  • The Exicure 52-week high stock price is 2.83, which is 119.4% above the current share price.
  • The Exicure 52-week low stock price is 1.09, which is 15.5% below the current share price.
  • The average Exicure stock price for the last 52 weeks is 1.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Exicure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.0910 2.8000 3.1500 1.0300 1.7700 -38.11%
2019 2.6560 2.6500 3.6500 2.1600 2.8600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.114B $0.017B
Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29